Core Insights - Target Hospitality reported a revenue of $69.9 million for the quarter ended March 2025, which is a decrease of 34.5% compared to the same period last year [1] - The earnings per share (EPS) for the quarter was -$0.05, down from $0.20 in the year-ago quarter, indicating a significant decline [1] - Despite the revenue drop, the reported revenue exceeded the Zacks Consensus Estimate of $65.37 million by 6.93% [1] - The EPS surprise was -150.00% compared to the consensus estimate of -$0.02 [1] Financial Performance Metrics - Revenue from Hospitality & Facilities Services - South was $36.07 million, surpassing the two-analyst average estimate of $35.79 million [4] - Revenue from All Other segments was $8.11 million, significantly higher than the estimated $1.64 million [4] - Government revenue reached $25.72 million, exceeding the average estimate of $23.71 million [4] - Adjusted Gross Profit for Hospitality & Facilities Services - South was $11.03 million, slightly below the estimated $11.52 million [4] - Adjusted Gross Profit for Government was $19.18 million, outperforming the average estimate of $16.15 million [4] Stock Performance - Shares of Target Hospitality have returned +6.9% over the past month, while the Zacks S&P 500 composite increased by +13.1% [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting potential for outperformance in the near term [3]

Core Insights - Telus reported $3.52 billion in revenue for Q1 2025, a year-over-year decline of 3.7% and a surprise of -0.94% compared to the Zacks Consensus Estimate of $3.56 billion [1] - The EPS for the quarter was $0.18, compared to $0.19 a year ago, with a surprise of +20.00% over the consensus estimate of $0.15 [1] Financial Performance - Telus shares returned +5.2% over the past month, while the Zacks S&P 500 composite increased by +9% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market [3] Subscriber Metrics - Mobile Phone Subscribers: 10.14 million, slightly below the average estimate of 10.17 million [4] - Connected Device Subscribers: 3.88 million, exceeding the average estimate of 3.82 million [4] - Internet Subscribers: 2.72 million, below the average estimate of 2.78 million [4] - TV Subscribers: 1.42 million, slightly above the average estimate of 1.4 million [4] - Security Subscribers: 1.14 million, matching the average estimate [4] - Residential Voice Subscribers: 1.02 million, in line with the average estimate [4] Churn and Net Additions - Mobile Phone Churn Rate: 1.1%, consistent with the average estimate [4] - Net Additions for Connected Device: 148 thousand, significantly above the average estimate of 90.6 thousand [4] - Net Additions for Internet: 21 thousand, slightly below the average estimate of 23.54 thousand [4] - Net Additions for TV: 27 thousand, exceeding the average estimate of 15.49 thousand [4] - Net Additions for Security: 15 thousand, below the average estimate of 17.42 thousand [4] - Net Additions for Residential Voice: -13 thousand, worse than the average estimate of -8.12 thousand [4]

Core Viewpoint - Aquestive Therapeutics reported a significant decline in revenue and earnings for the quarter ended March 2025, indicating potential challenges in financial performance and market expectations [1][3]. Revenue Performance - Total revenue for the quarter was $8.72 million, a decrease of 27.6% compared to the same period last year, and a miss of 28.14% against the Zacks Consensus Estimate of $12.14 million [1]. - Revenue from manufacturing and supply was $7.19 million, falling short of the three-analyst average estimate of $10.07 million, representing a year-over-year decline of 31.6% [4]. - License and royalty revenue amounted to $0.79 million, compared to the average estimate of $1.68 million, reflecting a year-over-year decrease of 30.2% [4]. - Co-development and research fees were reported at $0.42 million, slightly above the two-analyst average estimate of $0.40 million, showing a year-over-year increase of 3.7% [4]. Earnings Performance - The earnings per share (EPS) for the quarter was -$0.24, compared to -$0.17 in the same quarter last year, indicating a worsening in profitability [1]. - The EPS surprise was -41.18% against the consensus estimate of -$0.17 [1]. Stock Performance - Over the past month, shares of Aquestive Therapeutics have returned +13%, outperforming the Zacks S&P 500 composite's +3.8% change [3]. - The stock currently holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the broader market in the near term [3].

For the quarter ended March 2025, HudBay Minerals (HBM) reported revenue of $594.9 million, up 13.3% over the same period last year. EPS came in at $0.24, compared to $0.16 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $518.52 million, representing a surprise of +14.73%. The company delivered an EPS surprise of +140.00%, with the consensus EPS estimate being $0.10.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- an ...

Core Viewpoint - Brighthouse Financial reported mixed financial results for the quarter ended March 2025, with revenue growth but earnings per share (EPS) falling short of expectations [1][3]. Financial Performance - Revenue for the quarter was $2.16 billion, reflecting a year-over-year increase of 5.2%, but was below the Zacks Consensus Estimate of $2.3 billion, resulting in a surprise of -6.20% [1]. - EPS was reported at $4.17, down from $4.25 in the same quarter last year, and below the consensus estimate of $4.72, leading to an EPS surprise of -11.65% [1]. Key Metrics - Net flows for variable and shield level annuities were -$1.96 billion, worse than the average estimate of -$1.56 billion [4]. - The account value for variable and shield level annuities at the end of the period was $120.96 billion, slightly above the estimated $120.82 billion [4]. - Net flows for fixed annuities were -$431 million, significantly worse than the average estimate of -$21.07 million [4]. - The account value for fixed annuities was $19.36 billion, below the average estimate of $19.71 billion [4]. Revenue Breakdown - Net investment income was $1.29 billion, below the average estimate of $1.39 billion, but represented a year-over-year increase of 3% [4]. - Other revenues were reported at $136 million, below the average estimate of $146.63 million, reflecting a year-over-year decline of 6.2% [4]. - Premiums collected were $186 million, below the estimated $202.46 million, marking a year-over-year decrease of 7.9% [4]. - Universal life and investment-type product policy fees were $543 million, below the average estimate of $586.28 million, but showed a year-over-year increase of 24.5% [4]. - Total adjusted revenues for life insurance were $291 million, below the average estimate of $306.66 million, representing a year-over-year increase of 34.1% [4]. - Total adjusted revenues for annuities were $1.34 billion, slightly below the average estimate of $1.39 billion, with a year-over-year increase of 3.1% [4]. - Total adjusted revenues from run-off were $367 million, below the average estimate of $418.81 million, with a year-over-year increase of 3.1% [4]. - Total adjusted revenues from corporate and other segments were $154 million, below the average estimate of $181.42 million, reflecting an 11% year-over-year decline [4]. Stock Performance - Brighthouse Financial shares have returned +22.8% over the past month, outperforming the Zacks S&P 500 composite, which saw a +3.8% change [3]. - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3].

Core Insights - Aspen Aerogels reported revenue of $78.72 million for Q1 2025, a year-over-year decline of 16.7% and below the Zacks Consensus Estimate of $82.94 million, resulting in a surprise of -5.08% [1] - The company posted an EPS of -$0.06, compared to $0.01 a year ago, with an EPS surprise of +14.29% against a consensus estimate of -$0.07 [1] Revenue Breakdown - Energy Industrial segment revenue was $29.80 million, below the two-analyst average estimate of $36.16 million, reflecting a year-over-year increase of 2.4% [4] - Thermal Barrier segment revenue was $48.90 million, exceeding the average estimate of $45.23 million, but showing a significant year-over-year decline of 25.2% [4] Profitability Metrics - Gross profit for the Thermal Barrier segment was $11.12 million, lower than the average estimate of $14.98 million [4] - Gross profit for the Energy Industrial segment was $11.69 million, compared to the average estimate of $13.19 million [4] Stock Performance - Aspen Aerogels' shares have returned -15.5% over the past month, contrasting with the Zacks S&P 500 composite's increase of +13.7% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Insights - M/A-Com reported revenue of $235.89 million for the quarter ended March 2025, marking a year-over-year increase of 30.2% and exceeding the Zacks Consensus Estimate of $230.08 million by 2.52% [1] - The company's EPS for the same period was $0.85, up from $0.59 a year ago, also surpassing the consensus EPS estimate of $0.84 by 1.19% [1] Revenue Performance by Market Segments - Telecommunications revenue reached $65.17 million, exceeding the estimated $57.36 million, reflecting a year-over-year increase of 38.1% [4] - Industrial & Defense revenue was reported at $98.54 million, slightly below the average estimate of $100.92 million, with a year-over-year change of 8.4% [4] - Data Center revenue amounted to $72.18 million, surpassing the estimated $71.82 million, showing a significant year-over-year increase of 67.3% [4] Stock Performance - M/A-Com shares have returned +6.4% over the past month, while the Zacks S&P 500 composite has seen a +11.3% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

For the quarter ended March 2025, Sweetgreen, Inc. (SG) reported revenue of $166.3 million, up 5.4% over the same period last year. EPS came in at -$0.21, compared to -$0.23 in the year-ago quarter.The reported revenue represents a surprise of +0.51% over the Zacks Consensus Estimate of $165.46 million. With the consensus EPS estimate being -$0.21, the company has not delivered EPS surprise.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectati ...

Core Insights - Fox Factory Holding (FOXF) reported revenue of $355.03 million for the quarter ended March 2025, reflecting a 6.5% increase year-over-year and an 8.06% surprise over the Zacks Consensus Estimate of $328.55 million [1] - The company's EPS for the quarter was $0.23, down from $0.29 in the same quarter last year, with a 4.55% surprise over the consensus estimate of $0.22 [1] Revenue Performance - Net Sales for the Aftermarket Applications Group reached $111.91 million, exceeding the estimated $98.50 million, representing a 9.9% increase year-over-year [4] - Net Sales for the Powered Vehicles Group were $122.10 million, surpassing the estimated $106.05 million, marking a 3.4% increase compared to the previous year [4] - Net Sales for the Specialty Sports Group totaled $121.02 million, slightly below the estimated $122.45 million, but still showing a 6.6% increase year-over-year [4] Stock Performance - Over the past month, Fox Factory Holding's shares have returned -7.5%, contrasting with the Zacks S&P 500 composite's +11.3% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Rocket Companies (RKT) reported $1.3 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 6.3%. EPS of $0.04 for the same period compares to $0.04 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $1.22 billion, representing a surprise of +6.03%. The company has not delivered EPS surprise, with the consensus EPS estimate being $0.04.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street e ...